Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA

医学 肿瘤科 内科学 危险分层 乳腺癌 基线(sea) 癌症 生物 渔业
作者
Qiang Zhang,Zheng Cai,Lorenzo Gerratana,Andrew A. Davis,Paolo D’Amico,Akhil Chawla,Saya Liz Jacob,Youbin Zhang,Jianhua Jiao,Weijun Qin,Carolina Reduzzi,Lisa Flaum,Ami N. Shah,William John Gradishar
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:30 (16): 3470-3480 被引量:6
标识
DOI:10.1158/1078-0432.ccr-24-0535
摘要

PURPOSE: Early evaluation of tumor heterogeneity related to metastasis and outcomes is a major challenge in the management of advanced breast cancer (BCa) in the clinic. In this study, we introduced the value of baseline circulating tumor cells (CTC) and ctDNA for early differentiation of clinical stages, tumor heterogeneity, and prognosis in clinic. EXPERIMENTAL DESIGN: A total of 292 patients with BCa were enrolled in this study, including 254 Stage IV and 38 Stage III patients, and examined the baseline levels of CTCs, CTC-clusters, and plasma ctDNA before initiating therapies. Outcomes including progression-free survival (PFS) and overall survival were evaluated using proportional hazards regression analysis. RESULTS: The baseline CTCs, including HER2+ CTCs, in Stage IV patients were approximately 9.5 times higher than those detected in Stage III patients. Baseline CTC counts with a cutoff of 5 were significantly associated with the prognosis. Within each stage, patients with <5 CTCs had significantly longer PFS. Stage III patients with no CTCs exhibited the longest survival compared with patients with ≥1 CTC. CTC-clusters were only found in Stage IV patients, among whom 15 Stage IV patients with ≥5 CTC-clusters had the worst PFS compared with the 239 Stage IV patients with <5 CTC-clusters. Similar outcomes were observed in 28 out of 254 Stage IV patients who had at least one CTC-cluster detected, as these patients had shorter PFS compared with CTC-cluster negative group. The major differences in ctDNA mutations between patients with Stage III and Stage IV BCa were in PIK3CA and ESR1, which were associated with specific organ metastasis and worse outcomes. CONCLUSIONS: Assessing the baseline levels of CTCs, CTC-clusters, and mutational ctDNA profile could reliably aid in differentiation of clinical stage and early prediction of metastasis and outcomes in advanced BCa.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
月亮完成签到,获得积分10
1秒前
Nuyoahl完成签到 ,获得积分10
1秒前
易道聚焦完成签到,获得积分10
5秒前
cL完成签到 ,获得积分10
6秒前
littlelitter完成签到,获得积分10
6秒前
科研一坤年完成签到,获得积分10
7秒前
ghshen的应助被16601107082采纳,获得10
9秒前
科研通AI6.4的应助被小李子采纳,获得10
10秒前
怼怼完成签到 ,获得积分10
10秒前
xelloss完成签到,获得积分10
12秒前
Loong完成签到,获得积分10
12秒前
null的应助被littlelitter采纳,获得10
12秒前
智文完成签到 ,获得积分10
15秒前
uus13完成签到,获得积分10
15秒前
Jasper的应助被Xu采纳,获得10
15秒前
向日葵完成签到,获得积分10
15秒前
uus13发布了新的文献求助10
18秒前
18秒前
称心访卉完成签到,获得积分10
20秒前
赤小豆完成签到,获得积分10
22秒前
wangshuai完成签到 ,获得积分10
23秒前
碧蓝的小海豚完成签到 ,获得积分10
23秒前
禾苗完成签到 ,获得积分10
23秒前
夕阳完成签到 ,获得积分10
24秒前
年轻千萍完成签到,获得积分10
26秒前
刻苦的砖头完成签到 ,获得积分10
27秒前
27秒前
哈哈完成签到,获得积分10
28秒前
wali完成签到 ,获得积分0
28秒前
free2030完成签到,获得积分10
28秒前
王梦瑶完成签到 ,获得积分10
28秒前
541完成签到 ,获得积分10
28秒前
舟舟完成签到 ,获得积分10
31秒前
陈槊诸发布了新的文献求助10
33秒前
小小完成签到 ,获得积分10
33秒前
温柔的天奇完成签到 ,获得积分10
34秒前
随风而起完成签到,获得积分10
35秒前
YHBBZ完成签到 ,获得积分10
36秒前
水牛完成签到,获得积分10
36秒前
36秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166556
求助须知:如何正确求助?哪些是违规求助? 9559576
关于积分的说明 21750809
捐赠科研通 7757392
什么是DOI,文献DOI怎么找? 3429167
关于科研通互助平台的介绍 2553530
邀请新用户注册赠送积分活动 2473923